EODData

MEMBERSHIP REGISTER LOG IN

LSE, 0A4Y: Aim Immunotech INC

05 Dec 2025
LAST:

1.395

CHANGE:
 0.00		OPEN:
1.375		HIGH:
1.395		ASK:
0.000		VOLUME:
793
CHG(%):
0.00		PREV:
1.395		LOW:
1.375		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
05 Dec 251.3751.3951.3751.395793
04 Dec 251.3751.3951.3751.395793
03 Dec 251.3901.3951.3751.395793
02 Dec 251.4801.5001.4461.4469.1K
01 Dec 251.5101.5101.5101.510100
28 Nov 251.5101.5101.5101.5106.0K
27 Nov 251.5991.6111.5821.611342
26 Nov 251.5991.6111.5821.611342
25 Nov 251.3701.3701.3701.370250
24 Nov 251.3701.3701.3701.370250

PROFILE

Name:Aim Immunotech INC
About:AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. Its flagship products are Ampligen (rintatolimod), a drug of large macromolecular double-stranded ribonucleic acid molecules to treat chronic fatigue syndrome; and Alferon N Injection (Interferon alfa), a purified, natural-source, glycosylated, multi-species alpha interferon product for the treatment of genital warts. The company is also developing Ampligen for potential treatment of pancreatic, renal cell carcinoma, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, and prostate cancers, as well as for myalgic encephalomyelitis, Hepatitis B, HIV, COVID-19, and post-COVID conditions. The company was formerly known as Hemispherx Biopharma, Inc. and changed its name to AIM ImmunoTech Inc. in August 2019. AIM ImmunoTech Inc. was incorporated in 1966 and is headquartered in Ocala, Florida.
Address:2117 SW Highway 484, Ocala, FL, United States, 34473
Website:https://aimimmuno.com

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:58.85 
Price to Book:-0.30 
Profit Margin:0.20 
Operating Margin:-105.84 
Return on Assets:-1.05 
Return on Equity:0.03 
EPS Ratio:-0.40 
Revenue:121.0K 
EBITDA:7.19M 

TECHNICAL INDICATORS

MA5:1.432.4%
MA10:1.464.7%
MA20:1.485.8%
MA50:2.0748.6%
MA100:2.7496.2%
MA200:2.0949.5%
STO9:10.41 
STO14:34.85
RSI14:47.71
WPR14:-65.15
MTM14:-0.03
ROC14:-0.02 
ATR:0.06 
Week High:1.518.2%
Week Low:1.381.5%
Month High:1.8935.5%
Month Low:1.2649.5%
Year High:34.172,349.3%
Year Low:0.035,048.0%

RECENT SPLITS

Date Ratio
12 Jun 20250.01-1
11 Jun 20190.022727-1

RECENT DIVIDENDS

Date Amount
01 Dec 2022$0.00